Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
Background: Immune checkpoint inhibitor (ICI)-associated myocarditis is an uncommon and potentially fatal immune-related adverse event (irAE). Although corticosteroids are recommended as the first-line treatment by current guidelines, patients still have variable responses to it, and the guidelines...
Saved in:
Main Authors: | Cong Wang (Author), Jinyi Lin (Author), Yan Wang (Author), David H. Hsi (Author), Jiahui Chen (Author), Tianshu Liu (Author), Yuhong Zhou (Author), Zhenggang Ren (Author), Zhaochong Zeng (Author), Leilei Cheng (Author), Junbo Ge (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
by: Stefanovic F, et al.
Published: (2022) -
Tofacitinib for the Treatment of Steroid-Induced Rosacea
by: Li T, et al.
Published: (2022) -
Drug therapy for myocarditis induced by immune checkpoint inhibitors
by: Yihao Wu, et al.
Published: (2023) -
Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
by: Zou W, et al.
Published: (2021) -
Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
by: Yining Li, et al.
Published: (2019)